Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals
- PMID: 7902137
Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals
Abstract
This study investigates apoptosis as a mechanism for CD4+ T-cell depletion in human immunodeficiency virus type-1 (HIV-1) infection. Although several recent studies have shown that T cells of HIV-infected individuals show enhanced susceptibility to cell death by apoptosis, the mechanisms responsible for apoptosis are largely unknown. By using a flow cytometric technique and by morphology, we have quantitated the percentage of cells undergoing apoptosis in peripheral blood mononuclear cells (PBMCs) from HIV-seronegative donors and from HIV-infected asymptomatic patients. The PBMCs were cultured without any stimulus or with staphylococcus enterotoxin B, anti-T-cell receptor (TCR) alpha beta monoclonal antibody WT-31, or phytohemagglutinin for periods up to 6 days. In addition, we sought to determine whether cross-linking of CD4 followed by various modes of TCR stimulation in vitro could induce apoptosis in normal PBMCs. Here we show that (1) patient PMBCs undergo marked spontaneous apoptosis; (2) stimulation of T cells of patients as well as normal donors results in increased apoptosis; and (3) cross-linking of CD4 molecules is sufficient to induce apoptosis in CD4+ T cells if cross-linking is performed in unfractioned PBMCs, but not if CD4 molecules are cross-linked in purified T-cell preparations. These observations strongly suggest that accelerated cell death through apoptosis plays an important role in the pathogenesis of HIV-1 infection. At the same time, our observations implicate cross-linking of CD4 in vivo as a major contributor to this mechanism of accelerated cell death in HIV infection.
Similar articles
-
Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor-alpha secretion.Blood. 1994 Oct 15;84(8):2622-31. Blood. 1994. PMID: 7522637
-
HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4 T lymphocytes.J Acquir Immune Defic Syndr (1988). 1994 Apr;7(4):340-8. J Acquir Immune Defic Syndr (1988). 1994. PMID: 7907660
-
Apoptosis of CD4+ and CD8+ T cells isolated immediately ex vivo correlates with disease severity in human immunodeficiency virus type 1 infection.Pediatr Res. 1997 Nov;42(5):656-64. doi: 10.1203/00006450-199711000-00018. Pediatr Res. 1997. PMID: 9357940 Clinical Trial.
-
Increased susceptibility of CD4+ T cells from elderly individuals to HIV-1 infection and apoptosis is associated with reduced CD4 and enhanced CXCR4 and FAS surface expression levels.Retrovirology. 2015 Oct 9;12:86. doi: 10.1186/s12977-015-0213-1. Retrovirology. 2015. PMID: 26452480 Free PMC article.
-
Apoptosis in HIV-1 Infection.Behring Inst Mitt. 1996 Oct;(97):220-31. Behring Inst Mitt. 1996. PMID: 8950478 Review.
Cited by
-
Macrophage signaling in HIV-1 infection.Retrovirology. 2010 Apr 9;7:34. doi: 10.1186/1742-4690-7-34. Retrovirology. 2010. PMID: 20380698 Free PMC article. Review.
-
Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections.Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9431-5. doi: 10.1073/pnas.91.20.9431. Proc Natl Acad Sci U S A. 1994. PMID: 7937784 Free PMC article. Clinical Trial.
-
Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions.Microbiol Rev. 1996 Jun;60(2):386-406. doi: 10.1128/mr.60.2.386-406.1996. Microbiol Rev. 1996. PMID: 8801439 Free PMC article. Review.
-
Immune dysregulation and CD4+ T cell loss in HIV-1 infection.Springer Semin Immunopathol. 1997;18(3):285-303. doi: 10.1007/BF00813499. Springer Semin Immunopathol. 1997. PMID: 9089950 Review. No abstract available.
-
In vivo analysis of Fas/FasL interactions in HIV-infected patients.J Clin Invest. 1998 Jul 1;102(1):79-87. doi: 10.1172/JCI2691. J Clin Invest. 1998. PMID: 9649560 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials